PFAS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.260700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.293030E-01
Normal-vs-Stage2
7.035700E-03
Normal-vs-Stage3
1.087780E-02
Normal-vs-Stage4
5.484500E-02
Stage1-vs-Stage2
4.136200E-01
Stage1-vs-Stage3
4.273800E-02
Stage1-vs-Stage4
4.324600E-01
Stage2-vs-Stage3
8.045800E-02
Stage2-vs-Stage4
8.354000E-01
Stage3-vs-Stage4
6.767900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.443300E-03
Normal-vs-AfricanAmerican
1.645630E-01
Normal-vs-Asian
8.077900E-03
Caucasian-vs-AfricanAmerican
6.158200E-01
Caucasian-vs-Asian
4.782600E-01
AfricanAmerican-vs-Asian
2.862400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.403400E-04
Normal-vs-Female
3.294500E-02
Male-vs-Female
2.905800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.762200E-01
Normal-vs-Age(41-60Yrs)
6.586100E-02
Normal-vs-Age(61-80Yrs)
1.761630E-04
Normal-vs-Age(81-100Yrs)
3.889600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.754000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.336400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.774400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.446200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.920200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.150780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.462400E-02
Normal-vs-Daily Drinker
1.958480E-03
Normal-vs-Weekly Drinker
3.655400E-01
Normal-vs-Occasional Drinker
1.265440E-01
Normal-vs-Social Drinker
6.456400E-03
Non Drinker-vs-Daily Drinker
2.347000E-01
Non Drinker-vs-Weekly Drinker
3.839200E-01
Non Drinker-vs-Occasional Drinker
2.268200E-01
Non Drinker-vs-Social Drinker
9.983200E-01
Daily Drinker-vs-Weekly Drinker
1.570160E-01
Daily Drinker-vs-Occasional Drinker
8.661200E-01
Daily Drinker-vs-Social Drinker
1.686450E-01
Weekly Drinker-vs-Occasional Drinker
1.635400E-01
Weekly Drinker-vs-Social Drinker
4.289400E-01
Occasional Drinker-vs-Social Drinker
1.066630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.965600E-01
Normal-vs-Grade 2
6.534800E-01
Normal-vs-Grade 3
6.775600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.882400E-02
Grade 1-vs-Grade 3
4.992000E-01
Grade 1-vs-Grade 4
6.965600E-01
Grade 2-vs-Grade 3
1.947420E-01
Grade 2-vs-Grade 4
6.534800E-01
Grade 3-vs-Grade 4
6.775600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.750700E-04
Normal-vs-NonDiabetic
1.558130E-02
Diabetic-vs-NonDiabetic
2.723000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.420750E-03
Normal-vs-NoPancreatitis
1.122190E-02
Pancreatitis-vs-NoPancreatitis
1.477430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.476110E-03
Normal-vs-N1
9.098200E-03
N0-vs-N1
8.185400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.700700E-03
Normal-vs-TP53-NonMutant
2.116400E-02
TP53-Mutant-vs-TP53-NonMutant
3.759300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
